文献速递胃肠外科围术期管理与 ERAS

初次与修正代谢减重手术后30天结局的黑白种族差异:MBSAQIP数据库分析

Black-vs-white racial disparities in 30-day outcomes following primary and revisional metabolic and bariatric surgery: a MBSAQIP database analysis.
PubMed 文献 · Surg Endosc · 2025-01-27

基于MBSAQIP 2015-2020数据库的观察性队列研究,按19个协变量倾向评分1:1匹配后比较黑人与白人患者初次及修正代谢减重手术的30天结局。初次手术后黑人患者死亡、总发病率、严重事件、再手术、再入院及干预率均更高;修正手术后除再入院更高和手术部位感染更低外,多数结局无显著差异。

要点

  • 初次代谢减重手术后黑人患者死亡及多项并发症率显著高于白人患者。
  • 修正代谢减重手术后多数结局无显著种族差异,但再入院率黑人更高。
  • 需在国家层面减重手术评估中纳入公平性指标以识别和解决差异。

核心结论

  • 初次与修正代谢减重手术后种族差异表现不同,初次手术后黑人患者多项不良结局更高。

研究设计与样本

  • 观察性队列研究,使用2015-2020年MBSAQIP数据库成人初次或修正Roux-en-Y胃旁路、袖状胃切除、十二指肠转位或单吻合口胃旁路患者。
  • 初次手术组黑人112,495例、白人434,266例,修正手术组黑人10,838例、白人37,075例;按19个协变量倾向评分1:1匹配后初次219,114例、修正21,314例。
  • 采用McNemar检验比较MBSAQIP半年度报告中的11项术后结局及死亡。

主要发现

  • 初次手术后黑人vs白人:死亡0.1% vs 0.06%(p<0.001),总发病5.6% vs 4.7%(p<0.001),严重事件2.2% vs 1.9%(p<0.001)。
  • 初次手术后黑人vs白人:全部原因再手术1.2% vs 1.1%(p=0.006),相关再手术0.2% vs 0.1%(p=0.01),全部原因再入院4.6% vs 3.4%(p<0.001),相关再入院2.8% vs 1.9%(p<0.001),全部原因干预1.4% vs 1.1%(p<0.001),相关干预0.8% vs 0.6%(p<0.001)。
  • 修正手术后黑人vs白人:死亡、发病、严重事件、再手术、干预及出血无显著差异;全部原因再入院7.4% vs 6.2%(p=0.005),相关再入院4.4% vs 3.6%(p=0.01),手术部位感染1.6% vs 2.1%(p=0.04)。

临床怎么用

  • 围术期管理应关注黑人患者初次代谢减重手术后更高的死亡、并发症及再入院风险。
  • 修正代谢减重手术后应重点监测黑人患者的再入院风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have demonstrated Black-vs-White disparities in postoperative outcomes following primary metabolic and bariatric surgery (MBS). With the rising prevalence of MBS, it is important to examine racial disparities using quality indicators in primary and revisional procedures. This study explores Black-vs-White disparities in postoperative outcomes following primary and revisional MBS. METHODS: We performed an observational cohort study using the 2015-2020 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database of adults who underwent primary or revisional Roux-en-Y gastric bypass, sleeve gastrectomy, duodenal switch, or one-anastomosis gastric bypass. Black and White patients were 1:1 matched using propensity scores across 19 covariates for primary and revisional MBS groups. McNemar's tests were used to compare 11 postoperative outcomes from the MBSAQIP semi-annual report and death, between matched cohorts. RESULTS: We identified 112,495 Black and 434,266 White primary MBS and 10,838 Black and 37,075 White revisional MBS patients. A total of 219,114 primary and 21,314 revisional patients were matched. Following primary MBS, Black patients had higher rates of death (0.1% vs. 0.06%, p < 0.001), all occurrences morbidity (5.6% vs. 4.7%, p < 0.001), serious events (2.2% vs. 1.9%, p < 0.001), and all cause and related reoperations (1.2% vs. 1.1%, p = 0.006; 0.2% vs. 0.1%, p = 0.01), readmissions (4.6% vs. 3.4%, p < 0.001; 2.8% vs. 1.9%, p < 0.001), and interventions (1.4% vs. 1.1%, p < 0.001; 0.8% vs. 0.6%, p < 0.001) compared to White patients. In contrast, there were no significant Black-vs-White disparities in death, morbidity, serious events, reoperations, interventions, and bleeding following revisional MBS. Interestingly, Black patients had higher rates of all cause and related readmissions (7.4% vs. 6.2%, p = 0.005; 4.4% vs. 3.6%, p = 0.01), but lower surgical site infection rates (1.6% vs. 2.1%, p = 0.04). CONCLUSIONS: Our findings demonstrate a measurable contrast between racial disparities in postoperative outcomes following primary and revisional MBS. Equity-focused measures in national MBS assessments are needed to elucidate and address these disparities.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Lee S, Hutter MM, Jung JJ, et al. Black-vs-white racial disparities in 30-day outcomes following primary and revisional metabolic and bariatric surgery: a MBSAQIP database analysis. Surg Endosc. 2025. PMID: 39870832. doi:10.1007/s00464-025-11564-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。